IP Verse

Antineoplastic Combinations Of Neratinib And Capecitabine - EP3175853

PATENT ANALYSIS

Patent Details

Grant Date
Nov 1, 2023
Company
WYETH LLC
Oppositions

SANDOZ AG

More patents of Wyeth Llc

EP2676679

EP3246044

EP3175853

Want to monitor this patent?

Feel free to send us a message here and we will get back to you